6 Polycystic Kidney Disease Clinical Trials in Rochester, MI (2026)

Q: How do I join a clinical trial in Rochester?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Rochester research site will contact you.

Recruiting Polycystic Kidney Disease Studies in Rochester

NCT04338048Recruiting

Autosomal Dominant Polycystic Kidney Disease (ADPKD) Study

Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common genetic cause of renal failure. For several decades, ADPKD was regarded as an adult-onset disease. In the last decade, it has be...

Rochester, MI300 participantsChildren's Hospital of Philadelphia

View Study Details

NCT04111692Recruiting

A Prospective Observational Study of Foam Sclerotherapy .

An observational prospective study to determine the impact of foam sclerotherapy of large, dominant kidney/liver cysts on quality of life outcomes and kidney/liver cyst volumes at up to 12 months of f...

Rochester, MI100 participantsMayo Clinic

View Study Details

NCT04630613Recruiting

NOX4 and Related Biomarkers in ADPKD

To determine the value of NOX4, markers of mitochondria injury and function, and oxidative stress as real-time biomarkers to assess disease severity in patients with early autosomal dominant polycysti...

Rochester, MI60 participantsMayo Clinic

View Study Details

NCT04344769Recruiting

Characterization of the Nrf2 Response in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

The purpose of this study is to characterize oxidative stress and the Nrf2 antioxidant response in early stages of Autosomal Dominant Polycystic Kidney Disease (ADPKD), while identifying candidate bio...

Rochester, MI40 participantsMayo Clinic

View Study Details

NCT07228364Recruiting

Safety, Tolerability and Pharmacokinetics of AZD1613 in Adults With Autosomal Dominant Polycystic Kidney Disease

A study to investigate safety, tolerability, and pharmacokinetics of AZD1613 following subcutaneous or intravenous administration in participants with autosomal dominant polycystic kidney disease (ADP...

Rochester, MI40 participantsAstraZeneca

View Study Details

NCT04782258Recruiting

A Study to See Iftolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old withAutosomal Recessive Polycystic Kidney Disease (ARPKD)

To evaluate the safety of tolvaptan in pediatric subjects with ARPKD...

Rochester, MI20 participantsOtsuka Pharmaceutical Development & Commercialization, Inc.

View Study Details

About Polycystic Kidney Disease Clinical Trials in Rochester

Polycystic kidney disease (PKD) is a genetic disorder causing numerous fluid-filled cysts to grow in the kidneys, leading to kidney enlargement and progressive loss of function. Autosomal dominant PKD is the most common form. Treatment includes tolvaptan and management of complications.

There are currently 6 polycystic kidney disease clinical trials recruiting participants in Rochester, MI. These studies are seeking a combined 560 participants. Research is being sponsored by Children's Hospital of Philadelphia, Mayo Clinic, AstraZeneca and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Polycystic Kidney Disease Clinical Trials in Rochester — FAQ

Are there polycystic kidney disease clinical trials in Rochester?

Yes, there are 6 polycystic kidney disease clinical trials currently recruiting in Rochester, MI. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Rochester?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Rochester research site will contact you about next steps.

Are clinical trials in Rochester free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Rochester studies also compensate for your time and travel.

What polycystic kidney disease treatments are being tested?

The 6 active trials in Rochester are testing new therapies including novel drugs, biologics, and treatment approaches for polycystic kidney disease.

Data updated July 13, 2026 from ClinicalTrials.gov